Clinical Trial Update: Niacin, N-3 Fatty Acids and Insulin Resistance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating effects of niacin and n-3 fatty acids on insulin resistance in metabolic syndrome and hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Metabolic Syndrome

Drugs mentioned

• N-3 Fatty Acids (omega-3 fatty acids)
• Niacin (nicotinic acid)

Snippet

Sponsor: University of South Dakota | Conditions: Metabolic Syndrome, Hypertriglyceridemia | Phase 4 | Status: COMPLETED | Results posted: 2021-10-26